Search Results - "Studer, Deborah"
-
1
The BET inhibitor apabetalone decreases neuroendothelial proinflammatory activation in vitro and in a mouse model of systemic inflammation
Published in Translational neuroscience (01-01-2023)“…Brain vascular inflammation is characterized by endothelial activation and immune cell recruitment to the blood vessel wall, potentially causing a breach in…”
Get full text
Journal Article -
2
Linking Aortic Mechanical Properties, Gene Expression and Microstructure: A New Perspective on Regional Weakening in Abdominal Aortic Aneurysms
Published in Frontiers in cardiovascular medicine (15-02-2021)“…Current clinical practice for the assessment of abdominal aortic aneurysms (AAA) is based on vessel diameter and does not account for the multifactorial,…”
Get full text
Journal Article -
3
Ribosomal protein l13a as a reference gene for human bone marrow-derived mesenchymal stromal cells during expansion, adipo-, chondro-, and osteogenesis
Published in Tissue engineering. Part C, Methods (01-10-2012)“…In the field of human mesenchymal stromal cell (MSC) research, quantitative real-time reverse transcription-polymerase chain reaction (qPCR) is the method of…”
Get more information
Journal Article -
4
Molecular and biophysical mechanisms regulating hypertrophic differentiation in chondrocytes and mesenchymal stem cells
Published in European cells & materials (24-07-2012)“…Chondrocyte hypertrophy is one of the key physiological processes involved in the longitudinal growth of long bones, yet the regulation of hypertrophy is also…”
Get full text
Journal Article -
5
Apabetalone (RVX-208) reduces vascular inflammation in vitro and in CVD patients by a BET-dependent epigenetic mechanism
Published in Clinical epigenetics (12-07-2019)“…Apabetalone (RVX-208) is a bromodomain and extraterminal protein inhibitor (BETi) that in phase II trials reduced the relative risk (RR) of major adverse…”
Get full text
Journal Article -
6
-
7
Abstract 257: Apabetalone (RVX-208) Reduces Pathologic Cell-Cell Adhesion and Expression of Key Vascular Inflammation Markers in Monocytes, Endothelial Cells and Mouse Aorta
Published in Arteriosclerosis, thrombosis, and vascular biology (01-05-2018)“…Abstract only Apabetalone (RVX-208) is a bromodomain & extraterminal (BET) protein inhibitor, an epigenetic modifier of gene expression, currently in a phase 3…”
Get full text
Journal Article -
8
Human chondroprogenitors in alginate–collagen hybrid scaffolds produce stable cartilage in vivo
Published in Journal of tissue engineering and regenerative medicine (01-11-2017)“…The goal of this study was to evaluate human epiphyseal chondroprogenitor cells (ECPs) as a potential new cell source for cartilage regeneration. ECPs were…”
Get full text
Journal Article -
9
Retrieval of a Metabolite from Cells with Polyelectrolyte Microcapsules
Published in Biophysical journal (01-02-2011)Get full text
Journal Article -
10
-
11
Retrieval of a Metabolite from Cells with Polyelectrolyte Microcapsules
Published in Small (Weinheim an der Bergstrasse, Germany) (05-11-2010)“…To monitor cellular processes in individual cells, it is important to measure the concentrations of intracellular metabolites and to retrieve them for…”
Get full text
Journal Article -
12
Retrieval of a Metabolite from Cells with Polyelectrolyte Microcapsules
Published in Biophysical journal (01-01-2010)Get full text
Journal Article -
13
Abstract 14104: Apabetalone (RVX-208) Suppresses Expression of Key Vascular Inflammation Markers in Monocytes, Endothelial Cells and LPS-Challenged Mouse Liver and Monocyte Adhesiveness to Activated Endothelial Cells
Published in Circulation (New York, N.Y.) (06-11-2018)“…Apabetalone (RVX-208), a small molecule bromodomain & extraterminal (BET) protein inhibitor that selectively targets the second bromodomain (BD2), ameliorates…”
Get full text
Journal Article -
14
Design and synthesis of 4-substituted-8-(2-phenyl-cyclohexyl)-2,8-diaza-spiro[4.5]decan-1-one as a novel class of GlyT1 inhibitors: Achieving selectivity against the μ opioid and nociceptin/orphanin FQ peptide (NOP) receptors
Published in Bioorganic & medicinal chemistry letters (15-08-2006)“…A novel class of 4-substituted-8-(2-phenyl-cyclohexyl)-2,8-diaza-spiro[4.5]decan-1-ones have been discovered and developed as potent and selective GlyT1…”
Get full text
Journal Article